دورية أكاديمية

Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma

التفاصيل البيبلوغرافية
العنوان: Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma
المؤلفون: Fang Han, Junwei Liu, Hongwu Chu, Dan Cao, Jia Wu, Hong Fu, Anyang Guo, Weiqin Chen, Yingping Xu, Xiangdong Cheng, Yuhua Zhang
المصدر: Frontiers in Oncology, Vol 12 (2022)
بيانات النشر: Frontiers Media S.A., 2022.
سنة النشر: 2022
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: HCC, NDUFC1, senescence, NADH: ubiquinone oxidoreductase complexes I, prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: BackgroundNADH: ubiquinone oxidoreductase subunit C1(NDUFC1) encodes a subunit of the Complex I, which may support the structural stability of Complex I and assist in its biogenesis. The expression and functional roles of NDUFC1 in hepatocellular carcinoma (HCC) remain unknown.ResultWe knocked down the expression of NDUFC1 in HCC cell lines to explore the effects of NDUFC1 downregulation on HCC in vitro. MTT assay determined that downregulation of NDUFC1 significantly inhibited cell proliferation. Flow cytometry with (propidium iodide) PI staining indicated silencing of NDUFC1 arrested cell cycle of BEL-7404 cells at G2 phase and SK-HEP-1 cells at S/G2 phase. Annexin V-PI double staining and flow cytometric analysis showed that the downregulation of NDUFC1 significantly increased the population of apoptotic cells. Wound-healing assay and transwell assay indicated that the downregulation of NDUFC1 suppressed the migration and invasion of HCC cells. According to the detection of complex1 activity, we found that the activity of NDUFC1 silenced group decreased, whereas the content of ROS increased. Furthermore, combined with bioinformatics analysis of senescence-related genes, we found that the silence of NDUFC1 in HCC could induce senescence and inhibit autophagy. In addition, NDUFC1 could correlate positively with cancer-related pathways, among which the p53 pathways and the PI3K/Akt/mTOR pathways. Finally, NDUFC1 is high expression in HCC specimens. High NDUFC1 expression was associated with poor prognosis and was an independent risk factor for reduced overall survival (OS).ConclusionsOur study indicated, for the first time, that NDUFC1 is an independent risk factor for the poor prognosis of HCC patients. NDUFC1 may promote tumor progression by inhibiting mitochondrial Complex I and up-regulating ROS through multiple cancer-related and senescence-related pathways of HCC, including p53 pathways and PI3K/Akt/mTOR pathways. We suppose that NDUFC1 might be a potential target for the mitochondrial metabolism therapy of HCC.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2234-943X
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.860084/fullTest; https://doaj.org/toc/2234-943XTest
DOI: 10.3389/fonc.2022.860084
الوصول الحر: https://doaj.org/article/fb2cd21f14b541918f8b5288f2cff10fTest
رقم الانضمام: edsdoj.fb2cd21f14b541918f8b5288f2cff10f
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:2234943X
DOI:10.3389/fonc.2022.860084